Prognostic factors in colorectal cancer: Literature review for clinical application

Diseases of the Colon and Rectum

Volumn 41, Issue 8, 1998, Pages 1033-1049

  Ratto, Carlo ^a   Sofo, Luigi ^a   Ippoliti, Massimo ^a   Merico, Marta ^a   Doglietto, Giovanni Battista ^a   Crucitti, Francesco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bowel obstruction; Colorectal cancer; Distant metastases; Lymph node involvement; Multivariate analysis; Prognosis; Survival; Tumor stage; Univariate analysis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLON OBSTRUCTION; COLORECTAL CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SEX FACTORS; SURVIVAL RATE;

EID: 0031823620     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02237397     Document Type: Article

References (134)

1. O'Brien MJ. Cancer of the colon and rectum: current concepts of aetiology and pathogenesis. Ir J Med Sci 1988;157:5-15.
2. Crucitti F, Doglietto GB, Bellantone R, et al. Accurate specimen preparation and examination is mandatory to detect lymph nodes and avoid understaging in colorectal cancer. J Surg Oncol 1992;51:153-8.
3. Herrera-Ornelas L, Justiniano J, Castillo N. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253-6.
4. Cawthorn SJ, Gibbs NM, Marks CG. Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg 1986;73:58-60.
5. Wied U, Nilsson T, Knudsen JB, Sprechler M, Johansen A. Postoperative survival of patients with potentially curable cancer of the colon. Dis Colon Rectum 1985; 28:333-5.
6. Fielding LP, Phillips RK, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986;18:904-6.
7. Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Colorectal cancer: Dukes stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987; 122:1375-9.
8. Shepherd NA, Saraga E-P, Love SB, Jass JR. Prognostic factors in colonic cancer. Histopathology 1989;14: 613-20.
9. Hermanek P, Guggenmoons-Holzmann I, Gall FP. Prognostic factors in rectal carcinoma. Dis Colon Rectum 1989;32:593-9.
10. Albe X, Vassilakos P, Helfer-Guarnori K, et al. Independent prognostic value of ploidy in colorectal cancer. Cancer 1990;66:1168-75.
11. Korenaga D, Ueo H, Mochida K, et al. Prognostic factors in Japanese patients with colorectal cancer: the significance of large bowel obstruction - univariate and multivariate analyses. J Surg Oncol 1991;47: 188-92.
12. Garcia-Peche P, Vasquez-Prado A, Fabra-Ramis R, Trullenque-Peris R. Factors of prognostic value in long-term survival of colorectal cancer patients. Hepatogastroenterology 1991;38:438-43.
13. Ponz de Leon M, Sant M, Micheli A, et al. Clinical and pathologic prognostic indicators in colorectal cancer. Cancer 1992;69:626-35.
14. Lasser P, Mankarios H, Elias D, et al. Etude pronostique uni et multi-factorielle de 400 adenocarcinomes rectaux reseques. J Chir (Paris) 1993;2:57-65.
15. Hermanek P Jr, Wiebelt H, Riedl S, Staimmer D, Hermanek P. Langzeitergebnisse der chirurgischen therapie des coloncarcinoms. Chirurg 1994;65:287-97.
16. Deans GT, Patterson CC, Parks TG, et al. Colorectal carcinoma: importance of clinical and pathological factors in survival. Ann R Coll Surg Engl 1994;76: 59-64.
17. Ikeda Y, Mori M, Adachi Y, Matsushima T, Sugimachi K. Prognostic value of the histochemical expression of helix pomatia agglutinin in advanced colorectal cancer: a univariate and multivariate analysis. Dis Colon Rectum 1994;37:181-94.
18. Crucitti F, Sofo L, Doglietto GB, et al. Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol 1991;2(Suppl):76-82.
19. Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
20. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW, Melton LJ III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60: 2318-24.
21. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. Cancer 1994;73:2076-82.
22. Schmitz-Moormann P, Himmelmann GW, Baum U, Nilles M. Morphological predictors of survival in colorectal carcinoma: univariate and multivariate analysis. J Cancer Res Clin Oncol 1987;113:586-92.
23. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988;61: 386-95.
24. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992;102:1136-41.
25. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309-20.
26. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326:653-7.
27. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-417.
28. Solomon MJ, McLeod RS. Periodic health examination, 1994 update. 2. Screening strategies for colorectal cancer. Can Med Assoc J 1994;150:1961-70.
29. Robinson MH, Kronborg O, Williams CB, et al. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. Br J Surg 1995;82:318-20.
30. Spratt JS Jr, Spjut HJ. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 1967;20:1976-85.
31. Godwin JD, Brown CC. Some prognostic factors in survival of patients with cancer of the colon and rectum. J Chronic Dis 1975;28:441-54.
32. Copeland EM, Miller LD, Jones RS, Smith GP. Prognostic factors in carcinoma of the colon and rectum. Am J Surg 1968;116:875-81.
33. Wolmark N, Wieand HS, Rockette HE, Cruz I, Redmond CK, Fischer B. The prognostic significance of tumor and location and bowel obstruction in Dukes B and C colorectal cancer: findings from the NSABP clinical trials. Ann Surg 1983;198:743-52.
34. Dwight RW, Higgins GA, Keehan RJ. Factors influencing survival after resection in cancer of the colon and rectum. Am J Surg 1969;117;512-22.
35. Gilchrist RK, David VC. A consideration of pathological factors influencing five year survival in radical resection of the large bowel and rectum for carcinoma. Ann Surg 1947;126:421-38.
36. Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 1984;2:733-6.
37. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. Cancer 1986;57: 1866-70.
38. Willet C, Tepper JE, Cohen A, Orlow E, Welch C. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol 1985;3:379-84.
39. Ulin AW, Ehrlich EW. Current views related to management of large bowel obstruction caused by carcinoma of the colon. Am J Surg 1962;104:463-7.
40. Chang WY, Burnett WE. Complete colonic obstruction due to adenocarcinoma. Surg Gynecol Obstet 1962; 114:353-6.
41. Floyd CE, Cohn I Jr. Obstruction in cancer of the colon. Ann Surg 1967;165:721-31.
42. Glenn F, McSherry CK. Obstruction and perforation in colorectal cancer. Ann Surg 1971;173:983-92.
43. Welch JP, Donaldson GA. Management of severe obstruction of the large bowel due to malignant disease. Am J Surg 1974;127:492-9.
44. Miller LD, Boruchow IB, Fitts WT. An analysis of 284 patients with perforative carcinoma of the colon. Surg Gynecol Obstet 1966;123:1212-8.
45. Crowder VH Jr, Cohn I Jr. Perforation in cancer of the colon and the rectum. Dis Colon Rectum 1967;10: 415-20.
46. Welch JP, Donaldson GA. Perforative carcinoma of colon and rectum. Ann Surg 1974;180:734-40.
47. LoGerfo P, Herter FP. Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg 1975;181:81-4.
48. Herrera MA, Chu TM, Holyoke ED. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 1976;183:5-9.
49. Wanebo JH, Rao B, Pinsky CM, et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978;299: 448-51.
50. Band PR, Beck IT, Dinner PJ, Lentle BC, Amy R. Two year follow-up study of patients with known serum concentrations of carcinoembryonic antigen. Can Med Assoc J 1977;117:657-9.
51. Evans JT, Mittelman A, Chu M, Goldrosen MH, Minowada J, Howell J. Pre- and postoperative uses of CEA. Cancer 1978;42:1419-21.
52. Kohler JP, Simnonowitz D, Paloyan D. Pre-operative CEA level: a prognostic test in patients with colorectal carcinoma. Am Surg 1980;46:449-52.
53. Staab HJ, Anderer FA, Brummendorf T, Stumpf E, Fischer R. Prognostic value of pre-operative serum CEA level compared to clinical staging. 1. Colorectal carcinoma. Br J Cancer 1981;44:652-62.
54. Szymendera JJ, Nowacki MP, Szalowski AW, Kaminska JA. Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma. Dis Col Rectum 1982;25: 46-52.
55. Onetto M, Paganuzzi M, Secco GB, Momparler RL, Momparler LF, Riverd GE. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer. Biomed Pharmacother 1985;39:392-5.
56. Aabo K, Petersen H, Kjaer M. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patients' survival. Eur J Cancer Clin Oncol 1986;22:211-7.
57. Goslin R, Steele G, MacLntyre J, Charteries J. The use of pre-operative plasma CEA levels for the stratification of patients after curative resection of colorectal cancer. Ann Surg 1980;192:747-51.
58. Blake KE, Dalbow MH, Concannon JP, et al. Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel. Dis Colon Rectum 1982;25:24-32.
59. Lewi H, Blumgart LH, Carter DC, et al. Pre-operative carcinoembryonic antigen and survival in patients with colorectal cancer. Br J Surg 1984;71:206-8.
60. Rao AR, Kagan AR, Chan PM, Gilbert HA, Hintz BL, Nussbaum H. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer 1981;48:1492-5.
61. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1993;52: 1317-29.
62. Minsky BD, Mies C, Recht A, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. 1. Patterns of failure and survival. Cancer 1988;61: 1408-16.
63. Qizilbash AH. Pathologic studies in colorectal cancer: a guide to the surgical pathology examination of colorectal specimens and review of features of prognostic significance. Pathol Annu 1982;17:1-46.
64. Osnes S. Carcinoma of the colon and rectum: a study of 353 cases with special reference to prognosis. Acta Chir Scand 1956;110:378-88.
65. McSherry CK, Cornell GN, Glenn F. Carcinoma of the colon and rectum. Ann Surg 1969;169:502-12.
66. Yamaguchi A, Hirono Y, Fushida S, et al. DNA polymerase alfa positive-cell rate in colorectal cancer and its relationship to prognosis. Br J Cancer 1992;65: 421-4.
67. Grinnell RS. The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 1939;109:500-3.
68. Cohen AM, Wood WC, Gunderson LL. Pathological studies in rectal cancer. Cancer 1980;45:2965-8.
69. Wolmark N, Fisher ER, Wieand HS. The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes C colorectal cancer. Cancer 1984;53:2707-12.
70. Coller FA, Kay EB, MacIntyre RS. Regional lymphatic metastasis in carcinoma of the colon. Ann Surg 1941; 114:56-63.
71. Sontag SJ, Durczak C, Aranha GV. Fecal occult blood screening for colorectal cancer in a Veteran's Administration hospital. Am J Surg 1983;145:89-94.
72. Quirke P, Dixon MF, Clayden AD, et al. Prognostic-significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987;151:285-91.
73. Kokal WA, Gardine RL, Sheibani K, et al. Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg 1989;209:188-93.
74. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-59.
75. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Tomer M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-7.
76. Greenson JK, Isenhart CE, Riche R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes B colorectal cancer patients using monoclonal antibodies against cytokeratine and CC 49: correlation with long term survival. Cancer 1994;73:563-9.
77. Minsky BD, Mies C, Rich TA, Recht A. Lymphatic-vessels invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys 1989;17:311-8.
78. Khankhanien N, Maulight GM, Russel WO. Prognostic significance of vascular invasion in colorectal cancer of Dukes' B class. Cancer 1977;39:1195-200.
79. Heald RJ, Ryall RD. Recurrence and survival after total meso-rectal excision for rectal cancer. Lancet 1986;1: 1479-82.
80. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991;34:798-804.
81. Michelassi F, Vannucci L, Ayala JJ. Local recurrence after curative resection of colorectal adenocarcinoma. Surgery 1990;108:787-93.
82. Seefeld P, Bargen JA. The spread of carcinoma of the rectum: invasion of lymphatics, veins and nerves. Ann Surg 1943;118:76-90.
83. Krasna MJ, Flancbaum L, Cody RP, Shmibaum S, Ben Ari G. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988;61:1018-23.
84. Murray D, Hreno A, Dutton J, Murray DH. Prognosis in colon cancer: a pathologic reassessment. Arch Surg 1975;110:908-13.
85. Symonds DA, Vickery AL Jr. Mucinous carcinoma of the colon and rectum. Cancer 1976;37:1891-900.
86. Umpleby HC, Ranson DL, Williamson HC. Peculiarities of mucinous colorectal carcinoma. Br J Surg 1985;72: 715-8.
87. Walton WW Jr, Hagihara PF, Griffen WO Jr. Colorectal adenocarcinoma in patients less than 40 years old. Dis Colon Rectum 1976;19:529-34.
88. Trimpi HD, Bacon HE. Mucoid carcinoma of the rectum. Cancer 1951;4:597-609.
89. Sundbald AS, Paz RA. Mucinous carcinoma of the colon and the rectum and their relation to polyps. Cancer 1982;50:2504-9.
90. Bosman FT. Prognostic value of pathological characteristics of colorectal cancer. Eur J Cancer 1995;31A: 1216-21.
91. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
92. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-7.
93. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
94. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;238:193-7.
95. Gallick GE, Kurzrock R, Kloetzer WS, Arlinghaus RB, Gutterman JU. Expression of p21ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci USA 1985;82:1795-9.
96. Spandidos DA, Kerr IB. Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum. Br J Cancer 1984; 49:681-7.
97. Finkelstein SD, Sayegh R, Bakker A, Swalsky P. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 1993;128:526-31.
98. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327: 298-303.
99. Lee JC, Wang ST, Lai MD, Lin YJ, Yang HB. K-ras gene mutation is a useful predictor of the survival of early colorectal cancers. Anticancer Res 1996;16:3839-44.
100. Span M, Moerkerk PT, De Goeij AF, Arenas JW. A detailed analysis of k-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int J Cancer 1996;69:241-5.
101. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 over-expression and c-ki ras gene mutation in colorectal cancer. Gastroenterology 1993;104:57-64.
102. Moerkerk PT, Arends JW, Van Driel M, De Bruine A, De Goey A, Ten Kate J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994;54:3376-8.
103. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256: 102-5.
104. Ratto C, Flamini G, Sofo L, et al. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces. Dis Colon Rectum 1996;39:1238-44.
105. Watson JV, Sikora K, Evan GI. A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material. J Immunol Methods 1985;83:170-92.
106. Stewart J, Evan GI, Watson JV, Sikora K. Detection of c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer 1986;53:1-6.
107. Sikora K, Chan S, Evan GI, et al. C-myc oncogene expression in colorectal cancer. Cancer 1987;59: 1289-95.
108. Sun X-F, Carstensen JM, Zhang H, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992;340:1369-73.
109. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994;86:681-7.
110. Flamini G, Curigliano G, Ratio C, et al. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis. Eur J Cancer 1996;32A:802-6.
111. Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778-84.
112. Zeng ZS, Sarkis AS, Zhang ZF, et al. p-53 nuclear overexpression: an independent predictor of survival in lymph node positive colorectal cancer patients. J Clin Oncol 1994;12:2043-50.
113. Lazaris AC, Theodoropoulos GE, Anastassopoulos P, Nakopoulou L, Panoussopoulos D, Papadimitriou K. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma. Histol Histopathol 1995;10:661-8.
114. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. P53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991; 63:317-9.
115. Fante R, Di Gregorio C, Losi L, Roncucci L, Ponz de Leon M, Colorectal Cancer Study Group of the University and Health Care District of Modena. Clinicopathologic correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Ital J Gastroenterol 1996;28:205-10.
116. Poller DN, Baxter KJ, Shepherd NA. P53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 1997;75:87-93.
117. Pereira H, Silva S, Juliao R, Garcia P, Perpetua F. Prognostic markers for colorectal cancer: expression of p53 and BCL2. World J Surg 1997;21:210-3.
118. Starzynska T, Bromley M, Marliez K, Roberts SA, Ucinski M, Stern PC. Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma. Eur J Gastroenterol Hepatol 1997;9:183-6.
119. Leahy D, Salman R, Mulcahy H, Sheahan K, O'Donoghue DP, Parkfrey NA. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis. J Pathol 1996;180:364-70.
120. Smith DR, Ji CY, Goh HS. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 1996;74:216-23.
121. Kressner U, Lindmark G, Gerdin B, Påhlman L, Glimelius B. Immunohistochemical p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res 1996;16:951-7.
122. Grewal H, Guillem JG, Klimstra DS, Cohen AM. p53 nuclear overexpression may not be an independent prognostic marker in early colorectal cancer. Dis Colon Rectum 1995;38:1176-81.
123. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene which is altered in colorectal cancers. Science 1990;247:49-56.
124. Kern SE, Fearon ER, Tersmette KW, et al. Clinical and pathological associations with allelic loss in colorectal carcinomas. JAMA 1989;261:3099-103.
125. O'Connell MJ, Schaid DJ, Ganju V, Cunningham J, Kovach JS, Thibodeau SN. Current status of adjuvant chemotherapy for colorectal cancer: can molecular markers play a role in predicting prognosis? Cancer 1992;70(Suppl):1732-9.
126. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
127. Shibata D, Reale MA, Lavin P, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996;335:1727-32.
128. Ionov Y, Peinado MA, Malkhosyan S, Shibata S, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism of colonic carcinogenesis. Nature 1993;363:558-61.
129. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260:816-9.
130. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
131. Aaltonen LA, Peltomaki P, Mecklin J-P, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
132. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 1994;91:9871-5.
133. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
134. Bubb VJ, Curtis LJ, Cunningham C, et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 1996;12:2641-9.